肿瘤指南

订阅

MedSci主页 / 所有栏目 / 肿瘤指南

2021 AHNS共识声明：头颈部肿瘤生存者

2021-11-30 美国头颈学会 Laryngoscope Investigative Otolaryngology

头颈部肿瘤

2021年11月，美国头颈学会(AHNS)发布了头颈部肿瘤生存者共识。本文主要提供了头颈部癌症生存者的最佳实践和共识声明，内容涉及癌症监测、生活质量、健康维持。

中文标题：

2021 AHNS共识声明：头颈部肿瘤生存者

英文标题：

Head and neck cancer survivorship consensus statement from the American Head and Neck Society

发布机构：

美国头颈学会

发布日期：

2021-11-30

简要介绍：

2021年11月，美国头颈学会(AHNS)发布了头颈部肿瘤生存者共识。本文主要提供了头颈部癌症生存者的最佳实践和共识声明，内容涉及癌症监测、生活质量、健康维持。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 AHNS共识声明：头颈部肿瘤生存者.pdf)] GetToolGuiderByIdResponse(projectId=1, id=766131c002286e31, title=2021 AHNS共识声明：头颈部肿瘤生存者, enTitle=Head and neck cancer survivorship consensus statement from the American Head and Neck Society, guiderFrom=Laryngoscope Investigative Otolaryngology, authorId=0, author=, summary=2021年11月，美国头颈学会(AHNS)发布了头颈部肿瘤生存者共识。本文主要提供了头颈部癌症生存者的最佳实践和共识声明，内容涉及癌症监测、生活质量、健康维持。, cover=https://img.medsci.cn/2021128/1638958155067_1608702.png, journalId=0, articlesId=null, associationId=1307, associationName=美国头颈学会, associationIntro=, copyright=0, guiderPublishedTime=Tue Nov 30 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p>2021年11月，美国头颈学会(AHNS)发布了头颈部肿瘤生存者共识。本文主要提供了头颈部癌症生存者的最佳实践和共识声明，内容涉及癌症监测、生活质量、健康维持。</p>, tagList=[TagDto(tagId=661, tagName=头颈部肿瘤)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤, tenant=100), CategoryDto(categoryId=73, categoryName=头颈外科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=661, guiderKeyword=头颈部肿瘤, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=1806, appHits=127, showAppHits=0, pcHits=389, showPcHits=1679, likes=7, shares=27, comments=11, approvalStatus=1, publishedTime=Wed Dec 08 18:15:10 CST 2021, publishedTimeString=2021-11-30, pcVisible=1, appVisible=1, editorId=1608702, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=dajiong, createdTime=Wed Dec 08 18:14:49 CST 2021, updatedBy=1608702, updatedName=dajiong, updatedTime=Sat Jan 06 14:30:35 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 AHNS共识声明：头颈部肿瘤生存者.pdf)])
2021 AHNS共识声明：头颈部肿瘤生存者.pdf
下载请点击：
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1229034, encodeId=4dc4122903403, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4606479486, createdName=ms5000001683434619, createdTime=Mon Jun 27 21:40:59 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214304, encodeId=05a21214304ec, content=<a href='/topic/show?id=f94d4443055' target=_blank style='color:#2F92EE;'>#头颈部肿瘤#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44430, encryptionId=f94d4443055, topicName=头颈部肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Mon Apr 25 22:32:04 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197877, encodeId=1fc2119e877ad, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210815/d72794d7ec9c4b8ea0947c7f96ad73a5/0201ee887e4a4c5690b54a4917510b01.jpg, createdBy=3cc41662641, createdName=香姑娘, createdTime=Mon Feb 28 00:27:49 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083356, encodeId=ade010833568c, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Dec 22 23:55:24 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083355, encodeId=d25210833550e, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Dec 22 23:55:21 CST 2021, time=2021-12-22, status=1, ipAttribution=)]
    2022-06-27 ms5000001683434619

    学到了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1229034, encodeId=4dc4122903403, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4606479486, createdName=ms5000001683434619, createdTime=Mon Jun 27 21:40:59 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214304, encodeId=05a21214304ec, content=<a href='/topic/show?id=f94d4443055' target=_blank style='color:#2F92EE;'>#头颈部肿瘤#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44430, encryptionId=f94d4443055, topicName=头颈部肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Mon Apr 25 22:32:04 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197877, encodeId=1fc2119e877ad, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210815/d72794d7ec9c4b8ea0947c7f96ad73a5/0201ee887e4a4c5690b54a4917510b01.jpg, createdBy=3cc41662641, createdName=香姑娘, createdTime=Mon Feb 28 00:27:49 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083356, encodeId=ade010833568c, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Dec 22 23:55:24 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083355, encodeId=d25210833550e, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Dec 22 23:55:21 CST 2021, time=2021-12-22, status=1, ipAttribution=)]
    2022-04-25 病毒猎手

    #头颈部肿瘤#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1229034, encodeId=4dc4122903403, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4606479486, createdName=ms5000001683434619, createdTime=Mon Jun 27 21:40:59 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214304, encodeId=05a21214304ec, content=<a href='/topic/show?id=f94d4443055' target=_blank style='color:#2F92EE;'>#头颈部肿瘤#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44430, encryptionId=f94d4443055, topicName=头颈部肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Mon Apr 25 22:32:04 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197877, encodeId=1fc2119e877ad, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210815/d72794d7ec9c4b8ea0947c7f96ad73a5/0201ee887e4a4c5690b54a4917510b01.jpg, createdBy=3cc41662641, createdName=香姑娘, createdTime=Mon Feb 28 00:27:49 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083356, encodeId=ade010833568c, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Dec 22 23:55:24 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083355, encodeId=d25210833550e, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Dec 22 23:55:21 CST 2021, time=2021-12-22, status=1, ipAttribution=)]
    2022-02-28 香姑娘

    好东西

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1229034, encodeId=4dc4122903403, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4606479486, createdName=ms5000001683434619, createdTime=Mon Jun 27 21:40:59 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214304, encodeId=05a21214304ec, content=<a href='/topic/show?id=f94d4443055' target=_blank style='color:#2F92EE;'>#头颈部肿瘤#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44430, encryptionId=f94d4443055, topicName=头颈部肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Mon Apr 25 22:32:04 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197877, encodeId=1fc2119e877ad, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210815/d72794d7ec9c4b8ea0947c7f96ad73a5/0201ee887e4a4c5690b54a4917510b01.jpg, createdBy=3cc41662641, createdName=香姑娘, createdTime=Mon Feb 28 00:27:49 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083356, encodeId=ade010833568c, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Dec 22 23:55:24 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083355, encodeId=d25210833550e, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Dec 22 23:55:21 CST 2021, time=2021-12-22, status=1, ipAttribution=)]
    2021-12-22 一己怀

    谢谢分享

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1229034, encodeId=4dc4122903403, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4606479486, createdName=ms5000001683434619, createdTime=Mon Jun 27 21:40:59 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214304, encodeId=05a21214304ec, content=<a href='/topic/show?id=f94d4443055' target=_blank style='color:#2F92EE;'>#头颈部肿瘤#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44430, encryptionId=f94d4443055, topicName=头颈部肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Mon Apr 25 22:32:04 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197877, encodeId=1fc2119e877ad, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210815/d72794d7ec9c4b8ea0947c7f96ad73a5/0201ee887e4a4c5690b54a4917510b01.jpg, createdBy=3cc41662641, createdName=香姑娘, createdTime=Mon Feb 28 00:27:49 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083356, encodeId=ade010833568c, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Dec 22 23:55:24 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083355, encodeId=d25210833550e, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Dec 22 23:55:21 CST 2021, time=2021-12-22, status=1, ipAttribution=)]
    2021-12-22 一己怀

    谢谢分享

    0

相关指南

2021 EANO指南：脑膜瘤的诊断和治疗

欧洲神经肿瘤协会(EANO,European Association for Neuro-Oncology) · 2021-11-02

2018 CSCO临床指南：头颈部肿瘤的诊断和治疗（英文版）

中国临床肿瘤学会(CSCO,Chinese Society of Clinical Oncology) · 2019-02-20

2018 临床实践指南：头颈部肿瘤中三叉神经 (V) 及其分支轮廓

国外肿瘤科相关专家小组（统称） · 2018-09-08

2018 台湾共识建议：接受同步放化疗的头颈部肿瘤患者的营养干预

台湾多学科工作组（统称） · 2018-06-01

拓展阅读

2010版头颈部肿瘤综合治疗专家共识

中国抗癌协会头颈肿瘤外科专业委员会 · 2010-12-07

2011 RNAO 放射治疗在头颈部肿瘤的应用指南

安大略省注册护士协会(RNAO,Registered Nurses&#039;Association of Ontario) · 2011-01-01

2013 欧洲头颈部肿瘤颈部淋巴结分区指南（更新版）

国外肿瘤科相关专家小组（统称） · 2013-10-31

2016 ACS指南：头颈部肿瘤幸存者的护理

美国癌症学会(ACS,American Cancer Society) · 2016-03-22

2017 JSHNC临床实践指南：头颈部肿瘤

日本头颈部癌学会(JSHNC,Japan Society for Head and Neck Cancer) · 2017-03-18

头颈部肿瘤放疗者营养与支持治疗专家共识

中国抗癌协会肿瘤营养与支持治疗专业委员会 · 2018-01-03